Background-The hallmark lesion of arrhythmogenic right ventricular cardiomyopathy (ARVC) is fibrofatty scar replacement. We compared endocardial voltage mapping (EVM) and contrast-enhanced cardiac magnetic resonance (CE-CMR) for imaging scar lesions in ARVC patients. Methods and Results-We studied 23 consecutive ARVC patients (16 males; mean age, 38Ϯ12 years) who underwent RV EVM and CE-CMR and 37 control subjects. In 21 (91%) of 23 ARVC patients, RV EVM was abnormal, with a total of 45 electroanatomical scars (EAS): 17 (38%) in the inferobasal region, 12 (26.6%) in the anterolateral region, 8 (17.7%) in the RV outflow tract (RVOT), and 8 (17.7%) in the apex. RV delayed contrast enhancement (DCE) was found in 9 (39%) of 23 patients, with a total of 23 RV DCE scars: 4 (17.4%) in the inferobasal region, 9 (39.1%) in the anterolateral region, 4 (17.4%) in the RVOT, and 6 (26.1%) in the apex. There was a mismatch in 24 RV scars, with 22 EAS not confirmed by DCE and 2 DCE scars (both in the RVOT) undetected by EVM. In 9 (75%) of 12 patients with abnormal RV EVM/normal RV DCE, Ն1 DCEs were identified in the left ventricle (LV). Overall, ventricular DCE was detected in 78% of patients. No control subjects showed either EAS or DCE. Conclusions-EVM and CE-CMR allow identification of RV scar lesions in most ARVC patients. CE-CMR is less sensitive than EVM in identifying RV scar lesions. The high prevalence of LV DCE confirms the frequent biventricular involvement and indicates the diagnostic relevance of LV scar detection by CE-CMR. (Circ Arrhythm Electrophysiol. 2012;5:91-100.)
A rrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined cardiomyopathy characterized by the peculiar right ventricular (RV) involvement and the risk of arrhythmic sudden death. 1, 2 The hallmark lesion of ARVC is ventricular myocardial loss with fibrofatty replacement. 3 The assessment of mechanical consequences of myocardial fibrofatty replacement has been based on traditional imaging techniques, such as echocardiography and angiography. 4 -7 New techniques are available that allow direct imaging of ventricular scars. Endocardial voltage mapping (EVM) is an invasive technique that has been proved to accurately characterize the presence, location, and extent of RV scars in ARVC by demonstration of low-voltage regions, so-called electroanatomi-cal scars (EAS). 8 -13 A significant correlation between RV EAS and fibrofatty myocardial replacement was demonstrated by endomyocardial biopsy (EMB). Moreover, EVM has been clinically validated in the electrophysiological laboratory, where it is used for both mapping of substrate and catheter ablation of RV ventricular tachycardia (VT). 8 -14 However, because EVM is an invasive procedure and requires a cardiac catheterization, it cannot be proposed as a routine imaging study of ventricular scar in ARVC patients.
Clinical Perspective on p 100
Contrast-enhanced cardiac magnetic resonance (CE-CMR) with delayed contrast enhancement (DCE) sequences using gadolinium is an emerging technique that has the potential to detect ventricular scar in different pathological settings, including ARVC. 15 Compared with EVM, CE-CMR offers the advantage of being noninvasive and identifying left ventricular (LV) scars distinct from RV scars. 16, 17 Thus, the present study was designed to compare RV-EVM with DCE-CMR for imaging scar lesions in a consecutive series of ARVC patients fulfilling task force diagnostic criteria. 18 
Methods

Study Population and Diagnosis of ARVC
We evaluated 23 consecutive patients (16 males; mean age, 38Ϯ12 years) who fulfilled International Task Force criteria for diagnosis of ARVC. 18 In all patients, a cardiovascular evaluation included medical history, physical examination, 12-lead ECG, 24-hour Holter monitoring, signal-averaged ECG, exercise testing, 2D/color Doppler echocardiography, RV and LV cine angiography (in the right and left anterior oblique views), and coronary angiography. Technical equipment, protocols, and reference values have been reported in details elsewhere. 4, 8, 10 An EMB was performed in selected patients, including all those with LV DCE, for differential diagnosis with myocarditis and sarcoidosis, according to a previously reported protocol. 10, 18, 19 Patients were diagnosed as having ARVC regardless of the results of EVM and CMR.
Asymptomatic individuals, with a negative family history and no clinical evidence of heart disease, who underwent EVM and CE-CMR served as controls. The study was approved by the Institutional Review Board, and all patients gave their informed consent.
Imaging Study of a Ventricular Scar
All patients underwent additional EVM and CE-CMR for ventricular scar imaging.
Endocardial Voltage Mapping
Electroanatomical voltage mapping by the CARTO system (Biosense-Webster) was performed during sinus rhythm, as previously reported. 8, 10 In brief, a 7F Navi-Star (Biosense-Webster) catheter, with a 4-mm distal-tip electrode and a 2-mm ring electrode with an interelectrode distance of 1 mm, was introduced into the RV under fluoroscopic guidance and used as the mapping/ablation catheter. The catheter was placed at multiple sites on the endocardial surface to record bipolar electrograms from RV inflow, anterior free wall, apex, and RV outflow tract (RVOT). Bipolar electrogram signals (filtered at 10 -400 Hz and displayed at 100-mm/s speeds on the CARTO system) were analyzed with regard to amplitude, duration, relation to the surface QRS, and presence of multiple components. In our study, the following tools were used to avoid false low-voltage recordings: (1) adequate catheter contact was confirmed by concordant catheter tip motion with the cardiac silhouettes on fluoroscopy; (2) a recording was accepted and integrated into the map when the variability in cycle length, local activation time stability, and maximum beat-to-beat difference of the location of the catheter were Ͻ2%, Ͻ3 ms, and Ͻ4 mm, respectively (these parameters, combined with impedance measurements, were used to exclude low-amplitude signals due to poor endocardial catheter contact); and (3) in the presence of a low-voltage area, at least 3 additional points were acquired in the same site to confirm the reproducibility of the voltage measurement. 8 Particular attention was paid to validate the acquisition of endocardial points from the RV inferobasal region, because of the recognized risk of poor tissue contact in this area. Because of the potential high mapping error and to avoid overestimation of RV EAS as the result of inclusion of normal annular fibrous tissue, the immediate perivalvular areas (ie, within 1.5 cm of the valvular locations) were excluded in the analysis of endocardial low voltages. The bipolar voltage reference for normal and abnormal myocardium was based on values validated and used in previous voltage mapping studies. 8,11,12,20 -24 The color display for depicting normal and abnormal voltage myocardium ranged from red, representing EAS (amplitude, Ͻ0.5 mV), to purple, representing electroanatomical "normal tissue" (amplitude, Ն1.5 mV); intermediate colors represented the "border zone" (amplitudes, 0.5-1.5 mV). Regions showing low-amplitude electrograms were mapped with greater point density to delineate the extent and borders of EAS areas.
In 19 patients (asymptomatic, with a negative family history and no clinical evidence of heart disease) who underwent electrophysiological study for evaluation of supraventricular tachycardia, the same EVM protocol was followed. These data served as the control group.
Cardiac Magnetic Resonance Imaging
Cardiac magnetic resonance was performed on a 1.5-T scanner (Magnetom Avanto, Siemens Medical Solutions; Erlangen, Germany) using a comprehensive dedicated protocol. 16 
Sequence Views
All patients underwent a detailed CMR study protocol, including postcontrast sequences. Images were acquired using the following: (1) steady-state free precession sequence (true fast imaging in steady state) cine loops in sequential short-axis views and transverse long-axis views of RVOT to diaphragm; (2) T 1 -weighted turbo spin-echo images in the axial and short-axis planes; and (3) T 2weighted short tau inversion recovery for fat suppression. After intravenous administration of contrast agent (gadobenate dimeglumine, Multihance, Bracco, 0.2 mmol/kg of body weight), 2D segmented fast low-angle shot inversion recovery sequences, after at least 10 minutes, were acquired in the same views of cine images, covering the entire RV and LV. Considering the T 1 relaxation times of the tissues and the wash-in and wash-out kinetics of extracellular interstitial contrast agents, 25 the optimized T 1 nullifies the signal from normal myocardium in the images acquired 10 minutes after contrast medium injection. This allows clear visualization of the DCE areas, defined as a signal intensity at least 400% higher than the signal from normal (remote) myocardium or skeletal muscle. 26 
Image Analysis
Global ventricular volumes were calculated from the short-axis cine images using a summation of disk methods ("Simpson's rule"), with integration over the image slices using the standard software provided by the manufacturer. Biventricular volumes and systolic function were evaluated, comparing the values with reference ranges reported elsewhere. 18, 27, 28 Wall motion and trabeculation were evaluated by a subjective assessment, and localized aneurysms were defined as akinetic or dyskinetic regions of the ventricular wall showing bulging during diastole. Thinning of the RV wall was defined under a cutoff of 4 mm. The normal epicardial fat was distinguished from fibrofatty myocardial replacement by comparing corresponding slices on T 1 spin-echo (with/without fat saturation) and postcontrast inversion recovery sequences and by showing that fatty tissue and DCE images did not overlap. 29 Sections within 1 cm of the AV groove were excluded in the analysis because of the difficulty in distinguishing between normal epicardial fat and fibrofatty myocardial infiltration in basal images.
Eighteen healthy volunteers (asymptomatic, with a negative family history and no clinical evidence of heart disease) underwent CE-CMR according to the same protocol and served as control subjects.
Regional Scar Analysis
Analysis of the location of scars, either by EVM or DCE, included the following RV regions: inferobasal, anterolateral, RVOT, and apex. For regional analysis of LV DCE, a 17-segment model was used. 30 The images of RV-EVM and CE-CMR were evaluated as previously reported 10, 31 and analyzed independently by 3 observers (M.P.M., B.B., and F.C.) blinded to clinical and procedural characteristics.
Electrophysiological Study and VT Ablation
All patients underwent electrophysiological study and endocardial VT mapping/ablation, as reported in detail elsewhere. 8, 10 The site of origin of VT was established by activation mapping and/or pace mapping and catheter ablation accomplished during VT or at sinus rhythm by creating linear ablation lesions encircling and/or connecting EAS, as previously reported. 8 -12 
Data Analysis
Continuous variables are expressed as meanϮSD or median and interquartile ranges if not normally distributed. Categorical variables are expressed as frequencies. The distribution of the data was analyzed with a 1-sample Shapiro-Wilks test. Categorical differences between groups were evaluated by 2 or Fisher exact test. A comparison between 2 groups was examined with unpaired t test for normally distributed variables or with the nonparametric Mann-Whitney U test for highly skewed variables.
All P values reported are 2 sided, and PϽ0.05 was considered statistically significant. Concordance between EVM and DCE for scar detection in different RV regions was determined by the Cohen statistic test. Values were calculated on a per-region basis. The association and agreement of cine-CMR wall motion abnormalities with RV EAS and RV DCE were evaluated by the Cohen test. The sensitivity, specificity, and positive and negative predictive values were assessed in relation to task force criteria for diagnosis of ARVC. 18 Data were analyzed by SPSS 18 for Windows (SPSS Inc; Chicago, IL).
Results
Clinical Characteristics
The clinical characteristics of the study population are summarized in Table 1 . Eight patients had a family history of premature (aged Ͻ40 years) sudden death. Fourteen patients experienced symptoms such as palpitations (nϭ10), syncope (nϭ2), and presyncope (nϭ2). On basal ECG, 7 (30%) of the patients showed a QRS complex prolongation (Ն110 ms), 15 (65%) showed a T-wave inversion in right precordial leads, and 9 (39%) showed a T-wave inversion in inferior leads. Late potentials on signal-averaged ECG were detected in 13 (57%) of the patients. All patients had Ն1 episode of VT with a left bundle branch block pattern, either sustained (22%) or nonsustained (78%). Morphofunctional RV abnormalities, either global or regional, were observed at echocardiography/ angiography in all patients; LV dilatation/dysfunction was identified by echocardiography in 6 patients (26%) and by angiography in 9 patients (39%). In all 16 patients, EMB demonstrated a diagnostic amount of residual myocytes (Ͻ60%) and fibrofatty replacement, in the absence of histological features of noncaseous granulomatous and/or giant cell myocarditis.
Endocardial Voltage Mapping
The mean number of RV sites sampled by EVM was 172Ϯ19. Of 23 ARVC patients, 21 (91.3%) had an abnormal RV EVM showing Ն1 (mean, 2.29Ϯ0.6) low EAS (ie, low-amplitude areas, Ͻ0.5 mV) (Figures 1-3 ). All EAS were surrounded by a "border zone" with reduced signal amplitudes (0.5-1.5 mV) ( Figure 1 No patients from the control group showed RV EAS by EVM analysis ( Figure 4A ).
Mapping/Catheter Ablation of VT
Programmed ventricular stimulation induced a total of 16 VT morphologies in 13 (56%) of the 23 patients. The mean VT cycle length was 362Ϯ38 ms (range, 320 -390 ms) ( Table 1) . Mapping showed that VTs arose from the RV in each case: inferobasal region (nϭ10), anterolateral region (nϭ3), RVOT (nϭ2), and apex (nϭ1).
The arrhythmia circuit was initially localized and ablated by activation/entrainment mapping during VT. In 5 of these patients, in whom sustained VT remained inducible after electrophysiological mapping-guided ablation, an alternative substrate-based ablation approach was attempted at sinus rhythm by encircling RV EAS and/or connecting scar to scar. In all patients, the best VT pace mapping was obtained from the RV sites of the EAS. A mean of 28Ϯ16 radiofrequency lesions was applied per patient. The short-term success of catheter ablation was achieved in 11 (69%) of 16 VTs, with 8 of 11 originating from the inferobasal EAS ( Figure 3 ).
Cardiac Magnetic Resonance
Findings of cine-CMR and the tissue characterization study are reported in Table 2 . All patients had global and/or segmental RV dilatation/dysfunction, which was associated with wall thinning in 15 (65%) of the patients. LV dilatation/ dysfunction was demonstrated in 13 (57%) of the patients. Spin-echo sequences, with and without fat suppression, showed fatty infiltration of the RV wall in 11 (47.8%) of the patients and of the LV free wall in 2 (8.7%) of the patients.
RV DCE Scars
RV DCE was found in 9 (39%) of 23 patients (Figure 1 , Tables 3 and 4 ). A total of 23 RV DCE scars were identified: 4 (17.4%) in the inferobasal region, 9 (39.1%) in the anterolateral region, 4 (17.4%) in the RVOT region, and 6 (26.1%) in the apex. Affected regions showed abnormal motion on cine images in all patients.
In the 6 patients with diffuse RV involvement (Ͼ2 RV DCE scar regions), the RV ejection fraction was lower (37.6 [interquartile range, 34.5-39.1] versus 39.4 [interquartile range, 37.5-40]; Pϭ0.09) than in those with segmental RV disease (Յ2 RV DCE scar regions).
The interobserver and intraobserver reproducibility for RV DCE was 90% and 95%, respectively.
LV DCE Scars
LV DCE was found in 14 (61%) of 23 patients, either in the form of isolated LV involvement (nϭ9) or in combination with RV involvement (nϭ5). LV DCE involved the subepicardial and/or midwall layers of the anterolateral (nϭ10), inferolateral (nϭ9), anteroseptal (nϭ2), and posteroseptal (nϭ1) regions (Figures 1 and 2) . Overall, any ventricular DCE scar was detected in 78% of ARVC patients.
Control Group
Controls did not show evidence of DCE in the RV, LV, and septal myocardium ( Figure 4B and 4C) .
Correlation of Results
RV scars were detected in 21 patients (91%) by EVM versus 9 (39%) by CE-CMR, with a total of 45 EAS versus 23 DCE scars. The topographical comparison between EVM and CE-CMR findings showed a mismatch in 24 RV scar regions, with 22 EAS not confirmed by DCE (Figure 2 ), 3 in the anterolateral region, 2 on the apex, 4 in the RVOT, and 13 in the inferobasal walls, and 2 DCE scars (both in the RVOT) undetectable by EVM. The agreement test demonstrated a low concordance between EVM and CE-CMR (ϭ0.026), either overall or specific, for the detection of RV scar regions, with the exception of the apical region, for which there was a moderate agreement (ϭ0.444) ( Table 5 ). The P value was not significant for all 2 tests.
LV DCE was observed in 9 (75%) of the 12 patients who showed an abnormal RV EVM but a normal RV CE-CMR. The analysis of agreement between abnormal wall motion areas and scars showed a better concordance of wall motion abnormalities identified by cine-CMR with EAS compared with DCE for each RV region ( Figure 5 ). The best agreement between wall motion abnormalities and both EAS and DCE scars was found with the RVOT (ϭ0.57 [PϽ0.001] and ϭ0.52 [PϽ0.001], respectively) and RV anterolateral (ϭ0.55 [PϽ0.001] and ϭ0.44 [PϽ0.05], respectively) regions ( Figure 5 ).
Sensitivity and Specificity
Demonstration of EAS by EVM had a sensitivity of 91%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 90%, and a test accuracy of 95% to identify patients fulfilling task force criteria for ARVC ( Table 6 ). Detection of RV DCE by CE-CMR had a sensitivity of 39%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 56%, and a test accuracy of 66%. Adding LV DCE analysis increased sensitivity to 78%, negative predictive value to 78%, and test accuracy to 88% to identify patients fulfilling task force criteria for ARVC.
Discussion
This study was designed to evaluate the diagnostic accuracy of direct visualization of ventricular scar due to fibrofatty myocardial replacement, which is the hallmark pathological lesion of ARVC, and to compare RV-EVM with DCE-CMR for imaging a scar lesion in a consecutive series of ARVC patients fulfilling task force diagnostic criteria. 18 The major finding is that a ventricular scar was identified in most ARVC patients; however, there was a mismatch between the 2 techniques regarding the visualization of the RV scar, with fewer RV lesions detected by RV-DCE compared with RV-EVM. In ARVC patients with abnormal RV-EVM/ normal RV-DCE, we found a high prevalence of LV DCE that demonstrates the frequent biventricular involvement and indicates the diagnostic relevance of LV scar detection by DCE CMR.
RV Electroanatomical Scar
Electroanatomical voltage mapping has identified areas of myocardial loss by recording and spatially associating lowamplitude electrograms to generate a 3D electroanatomical ventricular map. 8,14,20 -23 In ARVC patients, RV EAS have been demonstrated to correlate with the histopathologic finding of myocardial atrophy and fibrofatty replacement at EMB. 8 EVM assesses the electric consequences of loss of RV myocardium, rather than the mechanical dysfunction, either regional or global, traditionally seen by echocardiography and angiography. EVM was reported to enhance the accuracy of differential diagnosis between ARVC and acquired inflammatory cardiomyopathy 8 or idiopathic RVOT tachycardia. 10 Ventricular tachycardia in ARVC is the result of a scarrelated macroreentry circuit, similar to that observed in the postmyocardial infarction setting. Hence, RV EVM-guided catheter ablation has been used as a successful therapeutic strategy for VT in ARVC. 11, 12 In the present study, RV EAS were identified by EVM in most ARVC patients. The high prevalence of RV low-voltage areas in our study population may be explained by the clinical and electrophysiological characteristics of patients who were probands with an overt disease phenotype, including VT, either sustained or nonsustained. Regional distribution of RV scars, with predominant involvement of the anterolateral and inferobasal RV regions, resembled that observed in autopsy heart specimens of patients who died suddenly from ARVC in whom the most severe atrophy and wall aneurysms were characteristically localized in the anteroinfundibular wall and underneath the tricuspid valve. 2, 3 
RV DCE Findings
Typical ARVC features on CMR consist of RV dilatation/ dysfunction, wall motion abnormalities, diastolic bulging, and thinning of the RV free wall. Moreover, CMR has the unique ability to detect intramyocardial fatty deposition, which may be differentiated by the adjacent myocardium, because of its brighter signal, with the spin-echo technique. 16, 17, 32 Although CMR provides an accurate quantitative analysis of RV volumes, 27,28 a significant interobserver variability in the interpretation of qualitative findings and segmental contraction analysis of the RV free wall has been reported. CMR has been implicated in overdiagnosis of ARVC based on the low specificity of qualitative findings, such as increased intramyocardial fat and wall thinning. 32 A CMR study demonstrated a 93.1% prevalence of RV wall motion abnormalities in healthy subjects, including areas of apparent dyskinesia (75.9%) and bulging (27.6%). 33 All these data indicate that conventional CMR may lead to misdiagnosis of ARVC by showing equivocal morphofunctional RV abnormalities. This is in keeping with our findings showing, at best, moderate agreement (Ͻ0.61) between abnormal wall motion areas and scars for all RV regions, when comparing wall motion abnormalities identified by cine-CMR with both DCE and EAS ( Figure 5) . A significant step forward in the imaging of ARVC has been the introduction of CE-CMR, which is based on the ability of gadolinium to identify areas of intramyocardial fibrosis. Previous studies demonstrated that a fibrofatty ventricular scar can be visualized as RV DCE in approximately one third to one half of ARVC patients. 16, 31, 34 Tandri et al 31 first reported RV DCE in 8 (67%) of 12 of patients with ARVC and demonstrated its relation to inducibility of sustained monomorphic VT at electrophysiological testing and fibrofatty myocardial changes at EMB. Sen-Chowdhry et al 16 reported unequivocal RV DCE in 13 (65%) of 20 patients who fulfilled task force diagnostic criteria for ARVC and were desmosomal gene mutation carriers. Santangeli et al 34 found RV DCE in 8 (53%) of 15 of patients with an ARVC diagnosis based on the task force criteria. The lack of RV DCE in a significant proportion of patients fulfilling the diagnostic criteria of ARVC was explained by early disease variants with a small amount of fibrofatty tissue or even by pure fatty variants of the disease undetectable by DCE techniques.
Our study confirmed a low prevalence (39%) of RV DCE in patients with clinical ARVC. Moreover, by specifically comparing EVM with CE-CMR for RV scar visualization, we found a significant mismatch between the 2 techniques (for imaging RV lesions), with fewer RV scars detected by RV-DCE compared with RV-EVM. The 19 EAS not confirmed by the DCE mostly affected the anterolateral and inferobasal RV regions. Previous reports comparing EVM with CMR findings in ARVC found a topographical relationship between low-voltage areas and RV dyskinesia/dilation. 9, 10 Because all our patients had clinically overt disease with significant RV dilatation/dysfunction, the low yield of RV DCE cannot be ascribed to early/minor disease forms but, more probably, can be explained by the low resolution of current CMR for the RV free wall and by the protocol design, with inversion time set to null LV myocardium and inversion recovery sequence not fat suppressed. The RV free wall is up to 4-mm thick and the motion artifacts often result in poor quality/spectral resolution to quantify RV wall thickness accurately. In addition, transmural myocardial atrophy and fibrofatty replacement in ARVC patients may lead to further RV free wall thinning (Ͻ2 mm) with a suboptimal contrast/ noise ratio between normal and scar tissue. 35 The inversion time required for optimal nulling of the myocardium probably differs between RV and LV, making inaccurate simultaneous examination of both ventricles with DCE imaging. 35 In addition, fat and fibrosis give the same signal on CE-CMR and partial volume effects make it difficult to distinguish the 2 different tissues, mostly in a thinned wall.
In addition to the limitations due to wall thinning and motion artifacts, the spatial resolution of CE-CMR is good for detecting large confluent areas of scarring, which are observed in diffuse disease variants, whereas it may fail in detecting an epicardial or focal RV scar. On the basis of pathological and CMR studies, 2,3,16,36 fibrofatty myocardial replacement in ARVC usually involves large epicardial/ midmural areas but reaches focally the RV endocardial layer, according to a "reversed" iceberg-like lesion model with a larger base on the epicardium and a thinner apex on the endocardium. The size of scar lesions reaching the endocardium may decline below the resolution power of CE-CMR, thus explaining the finding of the apparently normal RV wall. 29, 37 The findings of RVOT scars by CE-CMR, undetected by EVM in 2 patients, may be interpreted as false positive. As an alternative explanation, this finding may suggest limited EVM power for detection of scar lesions in this area. Because in our study EVM was limited to the endocardial side of the RV free wall, this may have underestimated or missed some nontransmural scar lesions.
LV DCE Findings
The results of the present study are in agreement with previous data suggesting a key role of late gadolinium enhancement for detection and morphological characterization of an LV myocardial fibrofatty scar in ARVC. 16, 17 LV involvement in ARVC was initially reported by pathological studies. 2, 3 Fibrofatty replacement of LV myocardium was a common histological finding in autopsy series of ARVC, with a reported prevalence up to 76%. 36 Fibrofatty changes affect both the septum and free wall, either diffusely or regionally, with a predilection for posteroseptal and posterolateral regions. Like RV lesions, the wave front of fibrofatty myocardial replacement in the LV progresses from the epicardium to the endocardium, with scar tissue frequently confined to subepicardial/midmural layers. 3, 36 Several clinico imaging studies confirmed the coexistence of LV involvement in ARVC, in the form of LV dilatation/dysfunction or ventricular arrhythmias. 38 -43 Sen-Chowdhry et al 16 found LV lesions in most ARVC patients, mostly thanks to DCE, which was a sensitive marker of fibrofatty replacement of LV myocardium. LV DCE in most ARVC patients occurred without the global and/or regional LV dysfunction. In our study, we observed a comparable prevalence of LV-DCE (78%), with a similar predominant involvement of inferolateral and inferoseptal LV regions and subepicardial/midmural locations. Our results confirm that LV lesions detected by CE-CMR represent a useful diagnostic "marker," regardless of their impact on LV function and electric instability. In both studies, there was a significantly lower prevalence of RV-DCE than LV-DCE, a finding that substantiates the current limited ability of DCE-CMR to visualize fibrofatty RV scars. In contrast, Dalal et al 44 reported no LV-DCE involvement in an ARVC population characterized by a high prevalence of plakophilin-2 gene mutations. LV involvement was originally considered an end-stage complication of ARVC, occurring late during the disease course and leading ultimately to biventricular pump failure. 3, 36 More recently, genotype-phenotype correlations have shown early and greater LV involvement in desmoplakin-gene mutations carriers. 17, 38 These findings support the modern concept of ARVC as a genetically determined biventricular cardiomyopathy. 5
Clinical Implications and Conclusions
The results of the present study confirm that EVM allows an accurate identification of RV EAS in patients with a clinical diagnosis of ARVC and support its clinical use for substratebased mapping and catheter ablation of RV tachycardia and for imaging-guided EMB.
Recently, the integration of CMR-derived scar maps with EVM has been successfully used for catheter ablation of LV VT arising from a postinfarct scar, thanks to the ability of CMR to identified nontransmural LV scars and infarct gray zones undetectable by EVM. 45 Our results demonstrate that currently available DCE-CMR visualize RV scars unsatisfactorily, limiting its usefulness for characterizing ARVC myocardial substrate and guiding interventional procedures, such as RV VT catheter ablation and imaging-guided RV EMB.
The high prevalence of LV involvement in our cohort of ARVC patients is in keeping with the perspective of biventricular disease and indicates the diagnostic relevance of LV scar detection by CE-CMR.
Despite the different accuracy of the 2 techniques for identification of a ventricular scar, CMR and EVM should not be considered alternative imaging tools in ARVC patients; rather, they should be used synergistically to combine their strategic diagnostic and prognostic information, mostly regarding quantitative evaluation of RV function and assessment of arrhythmogenic myocardial substrate.
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